Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.210
+0.070 (6.14%)
At close: Apr 28, 2026, 4:00 PM EDT
1.210
0.00 (0.00%)
After-hours: Apr 28, 2026, 6:57 PM EDT
Traws Pharma Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 2.79 | 0.23 | 0.23 | 0.23 | 0.23 | |
| Revenue Growth (YoY) | 1134.51% | - | - | - | -2.17% | |
| Gross Profit | 2.79 | 0.23 | 0.23 | 0.23 | 0.23 | |
| Selling, General & Admin | 8.52 | 12.29 | 9.09 | 8.45 | 9.43 | |
| Research & Development | 12.14 | 12.85 | 11.43 | 11.41 | 7.3 | |
| Operating Expenses | 20.67 | 25.14 | 20.52 | 19.85 | 16.72 | |
| Operating Income | -17.88 | -24.91 | -20.3 | -19.63 | -16.5 | |
| Interest & Investment Income | 0.46 | 0.51 | 1.39 | - | - | |
| Currency Exchange Gain (Loss) | 0.02 | -0.22 | -0.04 | - | - | |
| Other Non Operating Income (Expenses) | 26.57 | -24.44 | - | 0.66 | 0.33 | |
| EBT Excluding Unusual Items | 9.17 | -49.06 | -18.95 | -18.96 | -16.16 | |
| Pretax Income | 9.17 | -166.52 | -18.95 | -18.96 | -16.16 | |
| Earnings From Continuing Operations | 9.17 | -166.52 | -18.95 | -18.96 | -16.16 | |
| Net Income | 9.17 | -166.52 | -18.95 | -18.96 | -16.16 | |
| Preferred Dividends & Other Adjustments | 2.31 | -111.85 | - | - | - | |
| Net Income to Common | 6.87 | -54.67 | -18.95 | -18.96 | -16.16 | |
| Shares Outstanding (Basic) | 8 | 2 | 1 | 1 | 1 | |
| Shares Outstanding (Diluted) | 8 | 2 | 1 | 1 | 1 | |
| Shares Change (YoY) | 429.93% | 84.94% | 0.39% | 24.22% | 45.07% | |
| EPS (Basic) | 0.83 | -35.21 | -22.57 | -22.68 | -24.01 | |
| EPS (Diluted) | 0.83 | -35.21 | -22.57 | -22.75 | -24.01 | |
| Free Cash Flow | -18.19 | -29.79 | -17.95 | -16.29 | -19.49 | |
| Free Cash Flow Per Share | -2.21 | -19.19 | -21.38 | -19.48 | -28.94 | |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | |
| Operating Margin | -640.68% | -11022.12% | -8981.42% | -8684.51% | -7299.12% | |
| Profit Margin | 246.06% | -24192.03% | -8384.07% | -8391.15% | -7151.77% | |
| Free Cash Flow Margin | -651.79% | -13182.30% | -7940.71% | -7209.74% | -8622.57% | |
| EBITDA | -17.81 | -24.9 | -20.28 | -19.61 | -16.48 | |
| D&A For EBITDA | 0.06 | 0.01 | 0.02 | 0.01 | 0.01 | |
| EBIT | -17.88 | -24.91 | -20.3 | -19.63 | -16.5 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.